Core Laboratories N.V. provided earnings guidance for the third quarter of 2022. For the quarter, the company expected revenue to range from $123,000,000 to $129,000,000 and operating income of $10,100,000 to $13,300,000, yielding operating margins of approximately 9%. EPS for the third quarter of 2022 is expected to be $0.13 to $0.18.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.91 USD | -4.43% | -0.06% | +1.42% |
25/04 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
24/04 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.42% | 84Cr | |
+12.99% | 1.74TCr | |
-.--% | 763.81Cr | |
-11.15% | 271.77Cr | |
-20.63% | 260.65Cr | |
-25.63% | 188.16Cr | |
-11.39% | 105.64Cr | |
-10.28% | 102.83Cr | |
-1.04% | 75Cr | |
-20.36% | 74Cr |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Core Laboratories N.V. Provides Earnings Guidance for the Third Quarter of 2022